Wednesday 03 Sep 2014

Stock In News: NuPathe Inc (NASDAQ:PATH), James River Coal Company (NASDAQ:JRCC), GTx, Inc (NASDAQ:GTXI)

Northern, WI 01/22/2013 (NISMAGAZINE) – Wall Street Analyzed is a website dedicated to helping investors stay ahead of the market by providing trade alerts and other essential tools to our readers via eMail and Text Messages. To Join Our Text Message Alerts Service Just Text The Word GAINS To 555888 From Your Cell Phone. In this article we are focusing on NuPathe Inc (NASDAQ:PATH), James River Coal Company (NASDAQ:JRCC) and GTx, Inc (NASDAQ:GTXI)

NuPathe Inc (NASDAQ:PATH) will be acquired by Teva Pharmaceutical Industries for $3.65/share in cash, or $144M, to expand the company’s portfolio of medicines in the treatment of various  conditions that affecting the central-nervous-system (CNS).In addition to this upfront cash-payment, NuPathe Inc (NASDAQ:PATH) shareholders will also receive the rights to additional cash-payments of upto $3.15/share if the specified sales of NuPathe Inc (NASDAQ:PATH)’s migraine treatment named Zecuity are achieved over a period of time, said the Israel-based Teva. NuPathe Inc (NASDAQ:PATH) said that it had terminated its takeover-deal with the Endo Health Solutions Inc, saying that the offer that Teva had put forth,  represented a premium of around 28% over the upfront cash-payment that Endo offered and an equal amount of milestone-based payments.

Is PATH a solid investment at these levels? Find out here.

Tuesday’s trading for James River Coal Company (NASDAQ:JRCC)

James River Coal Company (NASDAQ:JRCC) is a coal company. In Tuesday’s trading session there was a drop of 6.67% in James River Coal Company (NASDAQ:JRCC). The shares opened at $1.35, climbed to an intraday high of $1.35 and closed at $1.26. Around 0.789M shares were traded over Tuesday’s session and the average volume of 0.682M shares were traded over a 30 day period. James River Coal Company (NASDAQ:JRCC) 52-week-low is $1.15 and its 52 week high is $3.50. The company has a market capitalization of $45.44 million.

How Should Investors Trade JRCC Now? Find out here.

Tuesday’s trading for GTx, Inc (NASDAQ:GTXI)

GTx, Inc (NASDAQ:GTXI) is a bio pharmaceutical company. In Tuesday’s trading session there was a drop of 6.64% in GTx, Inc (NASDAQ:GTXI). The shares opened at $2.13, which was the intraday high and closed at $1.97. Around 1.09M shares were traded over Tuesday’s session and the average volume of 0.916M shares were traded over a 30 day period. GTx, Inc (NASDAQ:GTXI) 52-week-low is $1.31 and its 52 week high is $7.24. The company has a market capitalization of $124.48 million.

How Should Investors Trade GTXI Now? Find out here.

About Wallstreetanalyzed.com

Join Our Mobile SMS Alerts By Texting Gains To 555888

Wallstreetanalyzed.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:

Wallstreetanalyzed.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.

Leave a Comment